CRGN

Curagen Corp. (MM) (CRGN)

Curagen Corp. (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CRGN

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2009/10/02	19 : 02	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/10/02	05 : 28	Edgar (US Regulatory)	(25-NSE)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/10/02	03 : 29	Business Wire	Celldex Therapeutics Announces Completed Acquisition of CuraGen Corporation	NASDAQ:CRGN	Curagen Corp. (MM)
2009/10/01	07 : 00	Business Wire	Celldex and CuraGen Stockholders Approve Acquisition of CuraGen Corporation	NASDAQ:CRGN	Curagen Corp. (MM)
2009/09/26	05 : 33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/09/26	02 : 33	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/09/03	19 : 01	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/08/29	06 : 27	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/08/18	05 : 50	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/08/11	00 : 59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/08/06	03 : 03	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/08/01	03 : 35	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/08/01	03 : 33	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/07/31	19 : 00	PR Newswire (US)	CuraGen Reports Second Quarter 2009 Financial Results	NASDAQ:CRGN
2009/06/23	06 : 07	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/06/20	02 : 45	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/06/19	02 : 43	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/06/17	19 : 30	PR Newswire (US)	CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer	NASDAQ:CRGN	Curagen Corp. (MM)
2009/06/11	06 : 02	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/06/10	04 : 22	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/06/04	04 : 42	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/06/02	19 : 30	PR Newswire (US)	CuraGen Updates CR011-vcMMAE Data at ASCO	NASDAQ:CRGN	Curagen Corp. (MM)
2009/05/30	06 : 26	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/05/30	06 : 24	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/05/30	05 : 50	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/05/30	05 : 35	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/05/30	05 : 33	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/05/29	19 : 54	Business Wire	Celldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen Corporation	NASDAQ:CRGN	Curagen Corp. (MM)
2009/05/28	19 : 30	PR Newswire (US)	CuraGen to Present CR011-vcMMAE Data at ASCO	NASDAQ:CRGN	Curagen Corp. (MM)
2009/05/20	04 : 15	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NASDAQ:CRGN	Curagen Corp. (MM)